Title : PRMT4 inhibitor TP-064 inhibits the pro-inflammatory macrophage lipopolysaccharide response in vitro and ex vivo and induces peritonitis-associated neutrophilia in vivo.

Pub. Date : 2021 Nov 1

PMID : 34311083






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PRMT4 inhibitor TP-064 inhibits the pro-inflammatory macrophage lipopolysaccharide response in vitro and ex vivo and induces peritonitis-associated neutrophilia in vivo. TP-064 coactivator-associated arginine methyltransferase 1 Mus musculus
2 Here we investigated the effect of PRMT4 inhibitor TP-064 treatment on macrophage inflammation in vitro and in vivo. TP-064 coactivator-associated arginine methyltransferase 1 Mus musculus
3 TP-064 treatment downregulated hepatic mRNA expression levels of the PRMT4 target genes glucose-6-phosphatase catalytic subunit (-50%, P<0.05) and the cyclin-dependent kinases 2 (-50%, P<0.05) and 4 (-30%, P<0.05), suggesting a direct transcriptional effect of PRMT4 also in hepatocytes. TP-064 coactivator-associated arginine methyltransferase 1 Mus musculus
4 TP-064 treatment downregulated hepatic mRNA expression levels of the PRMT4 target genes glucose-6-phosphatase catalytic subunit (-50%, P<0.05) and the cyclin-dependent kinases 2 (-50%, P<0.05) and 4 (-30%, P<0.05), suggesting a direct transcriptional effect of PRMT4 also in hepatocytes. TP-064 coactivator-associated arginine methyltransferase 1 Mus musculus
5 In conclusion, we have shown that the PRMT4 inhibitor TP-064 induces peritonitis-associated neutrophilia in vivo and inhibits the pro-inflammatory macrophage lipopolysaccharide response in vitro and ex vivo. TP-064 coactivator-associated arginine methyltransferase 1 Mus musculus